Actively Recruiting

Age: 18Years +
All Genders
NCT07405307

Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F

Led by Institute of Oncology Ljubljana · Updated on 2026-02-17

60

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Sarcopenia is a syndrome characterized by progressive loss of skeletal muscle mass and strength and is associated with worse outcomes in cancer patients. It can negatively affect prognosis, increase postoperative complications, reduce tolerance to systemic therapy, and impair quality of life. Sarcopenia may be present even in patients with preserved nutritional status or overweight. This study aims to evaluate the proportion of patients with gastrointestinal cancer who are at risk of sarcopenia, as assessed by the SARC-F screening questionnaire, before initiation of systemic treatment and during treatment. Patients with a positive screening result may be referred for further nutritional evaluation and assessment of sarcopenia severity using anthropometric measurements and DXA, according to standard clinical practice.

CONDITIONS

Official Title

Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (≥18 years) with gastrointestinal cancer
  • Planned for or receiving systemic anticancer treatment (adjuvant or metastatic)
  • Able to complete the SARC-F screening questionnaire
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Patients younger than 18 years
  • Unable to complete the questionnaire (e.g., severe cognitive impairment or inability to cooperate)
  • Not eligible for systemic anticancer treatment
  • Refusal to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institute of Oncology Ljubljana

Ljubljana, Slovenia, 1000

Actively Recruiting

Loading map...

Research Team

K

Klavdija Korošec

CONTACT

N

Neža Gros

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Sarcopenia Risk Screening in Patients With Gastrointestinal Cancer Using SARC-F | DecenTrialz